Applied Pharmaceutical Nanotechnology 2019

Details Coming Soon!

Fall 2019

Location to be Announced

Cambridge, MA 

 

APN 2018 Conference Program

 

Plenary Speakers for APN 2018

 

Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection

     
 

Samir Mitragotri, PhD, Professor of Bioengineering at Harvard University, Core Faculty at Wyss Institute

Strategies to Overcome Biological Hurdles for Nanoparticle Circulation and Targeting

     
 

Vladimir P. Torchilin, PhD, DSc, University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, School of Pharmacy, Bouve College of Health Sciences, Northeastern University

Next Generation of Drug Delivery Systems: Stimuli-Sensitive Combination Nanopreparations for Cancer

     

 

Confirmed Speakers for APN 2018

 

Marina A.Dobrovolskaia, Ph.D., MBA, PMP, Senior Principal Scientist, Head, Immunology Section, Nanotechnology Characterization Lab, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research

Achievements, Disappointments, and Lessons Learned from Immunotoxicity Studies of Nanotechnology-Formulated Complex Drugs

     
   

Daryl Drummond, PhD, Head of Research, Merrimack Pharmaceuticals

Clinical Translation of Non-targeted and Antibody-targeted Nanotherapeutics into the Clinic: Opportunities and Challenges

     
 

Konstantin Konstantinov, PhD, Senior Vice President Manufacturing and Process Sciences, Codiak BioSciences

Exosomes:  A New Therapeutic Modality and the Technology for Their Large Scale Manufacturing

     
 

Staci Sabnis, MS, Senior Scientist, Moderna Therapeutics

Messenger RNA as a Novel Therapeutic Approach

     
 

Johan Skog, PhD, Chief Scientific Officer, Exosome Diagnostics

Exosome Enrichment Enables Tissue Specific Liquid Biopsy Analysis

     
 

Kristy Wood, PhD, Senior Director, Intellia Therapeutics

Robust In Vivo Editing of Hepatocyte Target DNA Mediated by Lipid Nanoparticle Delivery of CRISPR/Cas9 Components

     
 

Ken Bernstein, Senior Scientist, Nanomedicine Development and Manufacturing, Pfizer

ACCURINS Polymeric Nanoparticles: Considerations for Scale-up and Tech Transfer

     
     

 

Proposed Sessions for 2018: 

Innovations in Nanotechnology

Break-Through Nanotechnology

Transforming the Science into the Clinic

 

 

 

Please Join our Linkedin Group

Sessions

Session I: Innovations in Nanotechnology

Session II: Break-Through Nanotechnology

Session III: Transforming the Science into the Clinic

Registration

Click here to register for the APN 2018 conference online.

APN 2018 will take place October 24, 2018 at:

Pfizer, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy